DOES SUPPRESSION OF RESPONSIVENESS TO β‐ADRENOCEPTOR ACTIVATION EXPLAIN THE ENHANCEMENT OF VASOCONSTRICTOR RESPONSES BY α2‐ADRENOCEPTOR AGONISTS?